Profile
| Metric | Value |
|---|---|
| Full Name | Regeneron Pharmaceuticals, Inc. |
| Ticker | NASDAQ: REGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | |
| Website | regeneron.com |
| Employees | 15,182 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $741.45 | |
| Price, 1D Change | -1.07% | |
| Market Cap | $78B | |
| TTM Dividend Yield | 0.24% | |
| PE Ratio | 17.75 | |
| Beta | 0.57 | |
| Revenue | $14B | |
| Revenue, 1Y Change | +8.27% | |
| EPS | $38.34 | |
| EPS, 1Y Change | +10.25% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.88 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $38.34 | |
| EPS Estimate | $43.16 | |
| EPS Est. Change | +12.58% | |
| Revenue | $14.20B | |
| Revenue Estimate | $14.22B | |
| Revenue Est. Change | +0.11% | |
| Current Price | $741.45 | |
| Price Target | - | $855.00 |
| Price Tgt. Change | - | +15.31% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $44.92 | $38.34 | -14.66% | |
| $43.16 | N/A | +12.58% | |
| $48.21 | N/A | +25.75% | |
| $46.95 | N/A | +22.46% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.16B | $14.20B | +0.29% | |
| $14.22B | N/A | +0.11% | |
| $15.64B | N/A | +10.10% | |
| $16.84B | N/A | +18.58% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +8.55% | |
| Price, 3Y | +0.68% | |
| Market Cap, 1Y | +4.35% | |
| Market Cap, 3Y | -3.21% | |
| Revenue, 1Y | +8.27% | |
| Revenue, 3Y | -11.63% | |
| EPS, 1Y | +10.25% | |
| EPS, 3Y | -46.73% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $741.45 | |
| SMA 200 | $618.50 | |
| SMA 200 vs Price | -16.58% | |
| SMA 50 | $755.53 | |
| SMA 50 vs Price | +1.90% | |
| Beta | 0.57 | |
| ATR | $20.66 | |
| 14-Day RSI | 44.56 | |
| 10-Day Volatility | 22.09% | |
| 1-Year Volatility | 41.18% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.88 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $14.20B | |
| EPS | $38.34 | |
| Gross Profit | $11.75B | |
| Gross Margin | 82.74% | |
| Operating Profit | $4.09B | |
| Operating Margin | 29.39% | |
| Net Income | $4.41B | |
| Net Margin | 31.07% | |
| EBITDA | $5.32B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.07 | |
| 4.73 | ||
| 3.95 | ||
| - | ||
| 5 | ||
| 7.94 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 17.75 | |
| 5.47 | ||
| 2.52 | ||
| 16.57 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $29.35B | |
| $2.49B | ||
| $37.85B | ||
| $18.66B | ||
| $8.50B | ||
| $3.94B | ||
| Total Debt | $2.94B | |
| $30.30M | ||
| $789.50M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $10.11B | ||
| $8.14B | ||
| $2.45B | ||
| $2.95B | ||
| $482.90M | ||
| $0.00 | ||
| $367.30M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $4.42B | ||
| -$2.47B | ||
| -$2.20B | ||
| Capex | $881.60M | |
| $3.54B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Evercore ISI Group | → | |
| Truist Securities | → | |
| B of A Securities | → | |
| Morgan Stanley | → | |
| Wells Fargo | → | |
| Canaccord Genuity | → | |
| BMO Capital | → | |
| Morgan Stanley | → | |
| Scotiabank | → | |
| HSBC |
Analyst sentiment
Institutional ownership
Screeners with REGN
FAQ
What is the ticker symbol for Regeneron Pharmaceuticals, Inc.?
The ticker symbol for Regeneron Pharmaceuticals, Inc. is NASDAQ:REGN
Does Regeneron Pharmaceuticals, Inc. pay dividends?
Yes, Regeneron Pharmaceuticals, Inc. pays dividends. The last payment was $0.88, with an ex-dividend date on November 20, 2025
What sector is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Regeneron Pharmaceuticals, Inc. in?
Regeneron Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Regeneron Pharmaceuticals, Inc. based in?
Regeneron Pharmaceuticals, Inc. is headquartered in United States
When did Regeneron Pharmaceuticals, Inc. go public?
Regeneron Pharmaceuticals, Inc. initial public offering (IPO) was on April 2, 1991
Is Regeneron Pharmaceuticals, Inc. in the S&P 500?
Yes, Regeneron Pharmaceuticals, Inc. is included in the S&P 500 index
Is Regeneron Pharmaceuticals, Inc. in the NASDAQ 100?
Yes, Regeneron Pharmaceuticals, Inc. is included in the NASDAQ 100 index
Is Regeneron Pharmaceuticals, Inc. in the Dow Jones?
No, Regeneron Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Regeneron Pharmaceuticals, Inc. last earnings report?
Regeneron Pharmaceuticals, Inc.'s most recent earnings report was on October 28, 2025
When does Regeneron Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Regeneron Pharmaceuticals, Inc. is January 30, 2026
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn